CNNC (Cannonau) Operating Cash Flow per Share: $0.00 (TTM As of Mar. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cannonau Operating Cash Flow per Share?

Cannonau CNNC Operating Cash Flow per Share is $0.00 as of Mar. 2024.

Cannonau's operating cash flow per share for the three months ended in Mar. 2024 was $0.00. Cannonau's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Cannonau's Operating Cash Flow per Share or its related term are showing as below:

CNNC's 3-Year OCF Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.3
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Cannonau Operating Cash Flow per Share Related Terms

Cannonau Operating Cash Flow per Share Historical Data

* Premium members only.

The historical data trend for Cannonau's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannonau Operating Cash Flow per Share Chart

Cannonau Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.78 -0.00 -0.00 0.00 0.00

Cannonau Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CNNC vs KOAN, THCT, RLBD: Operating Cash Flow per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cannonau's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannonau Price-to-Operating-Cash-Flow vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannonau's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cannonau's Price-to-Operating-Cash-Flow falls into.


Cannonau Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Cannonau's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )=Cash Flow from Operations (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=0/242.816
=0.00

Cannonau's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )=Cash Flow from Operations (Q: Mar. 2024 )/Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
=0/241.816
=0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Operating Cash Flow per Share of $0.00 mean?
Cannonau (CNNC) has a Operating Cash Flow per Share of $0.00 as of Mar. 2024. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Cannonau and its competitors.
Is Cannonau's Operating Cash Flow per Share too high?
Cannonau's current Operating Cash Flow per Share is $0.00.
How does Cannonau's Operating Cash Flow per Share compare to KOAN and THCT?
Cannonau's Operating Cash Flow per Share of $0.00 can be compared against companies in the Drug Manufacturers industry. The industry median Operating Cash Flow per Share is 7.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Cash Flow per Share for a Drug Manufacturers company?
The median Operating Cash Flow per Share among Drug Manufacturers companies is 7.30, based on 760 companies in the industry. Companies in the top quartile (top 25%) have a Operating Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Operating Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Cash Flow per Share mean?
A high Operating Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Cannonau and its competitors. For the Drug Manufacturers industry, the median Operating Cash Flow per Share is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannonau's current Operating Cash Flow per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannonau stock overvalued right now?
Cannonau (CNNC) has a current Operating Cash Flow per Share of $0.00. The current Operating Cash Flow per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Cash Flow per Share calculated?
Operating Cash Flow per Share is calculated from a company's financial statements. For Cannonau (CNNC), the current Operating Cash Flow per Share is $0.00 as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cannonau Business Description

Address 937 Old Seneca Turnpike Road, Skaneateles, NY, USA, 13252-9318
Cannonau Corp is using cutting-edge nanotechnology plans to offer Cannabidiol (CBD) for improved bioavailability and maximum benefit. It believes that its formulas can be easily incorporated into a wide, offering customers an advantage when it counts.